| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 733070 | 86655 | CITICOLINA KERN PHARMA 1.000 MG SOLUCIÓN ORAL EFG | CITICOLINA KERN PHARMA 1.000 MG SOLUCIÓN ORAL EFG, 10 sobres de 10 ml | 1.000 mg | 35 | 10 | 64 | 10 sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86655/86655_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86655/86655_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2022-03-21 | 1 | 1 | 1 | 2022-03-22 | 2022-03-21 | 1 | 2023-03-13 | View Edit Delete | ||||||||||||
| 733071 | 86655 | CITICOLINA KERN PHARMA 1.000 MG SOLUCIÓN ORAL EFG | CITICOLINA KERN PHARMA 1.000 MG SOLUCIÓN ORAL EFG, 30 (3 x 10 sobres) sobres de 10 ml | 1.000 mg | 35 | 30 | 64 | 30 (3 x 10 sobres) sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86655/86655_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86655/86655_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2022-03-21 | 1 | 1 | 1 | 2022-03-22 | 2022-03-21 | 1 | 2023-03-13 | View Edit Delete | ||||||||||||
| 733072 | 86656 | CITICOLINA NORMOGEN 1000 MG SOLUCIÓN ORAL EFG | CITICOLINA NORMOGEN 1000 MG SOLUCIÓN ORAL EFG, 10 sobres de 10 ml | 1.000 mg | 35 | 10 | 64 | 10 sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86656/86656_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86656/86656_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-03-21 | 1 | 1 | 1 | 2022-03-22 | 2022-03-21 | 1 | 2023-03-13 | View Edit Delete | ||||||||||||
| 733073 | 86656 | CITICOLINA NORMOGEN 1000 MG SOLUCIÓN ORAL EFG | CITICOLINA NORMOGEN 1000 MG SOLUCIÓN ORAL EFG, 30 (3 x 10) sobres de 10 ml | 1.000 mg | 35 | 30 | 64 | 30 (3 x 10) sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86656/86656_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86656/86656_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2022-03-21 | 1 | 1 | 1 | 2022-03-22 | 2022-03-21 | 1 | 2023-03-13 | View Edit Delete | ||||||||||||
| 735115 | 86878 | ULTRA-LEVURA 250 MG POLVO Y DISOLVENTE PARA SUSPENSION ORAL | ULTRA-LEVURA 250 MG POLVO Y DISOLVENTE PARA SUSPENSION ORAL, 10 frascos | 250 mg | 6 | 10 | 17 | 10 frascos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86878/86878_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86878/86878_p.pdf | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68155 | 29563 | 2022-04-19 | 1 | 1 | 1 | 2022-04-20 | 2022-04-19 | 1 | 2025-07-10 | View Edit Delete | ||||||||||||
| 762709 | 88820 | FUCIBET LIPID 20 MG/G + 1 MG/G CREMA | FUCIBET LIPID 20 MG/G + 1 MG/G CREMA, 1 tubo de 30 g | 1 mg/g + 20 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88820/88820_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88820/88820_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8764 | 34965 | 2023-05-24 | 1 | 1 | 1 | 2023-05-24 | 2023-05-24 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 762710 | 88820 | FUCIBET LIPID 20 MG/G + 1 MG/G CREMA | FUCIBET LIPID 20 MG/G + 1 MG/G CREMA, 1 tubo de 60 g | 1 mg/g + 20 mg/g | 44 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88820/88820_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88820/88820_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8764 | 34965 | 2023-05-24 | 1 | 1 | 1 | 2023-05-24 | 2023-05-24 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 763735 | 89150 | TOSHEDRA 7 MG/ML JARABE | TOSHEDRA 7 MG/ML JARABE, 150 ml | 7 mg/ml | 6 | 150 | 26 | 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89150/89150_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89150/89150_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2023-11-13 | 1 | 1 | 1 | 2023-11-14 | 2023-11-13 | 1 | 2024-07-12 | View Edit Delete | ||||||||||||
| 763737 | 89151 | TOSHEDRA 35 MG JARABE EN SOBRES | TOSHEDRA 35 MG JARABE EN SOBRES, 20 sobres de 5 ml | 35 mg | 35 | 20 | 64 | 20 sobres de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89151/89151_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89151/89151_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2023-11-13 | 1 | 1 | 1 | 2023-11-14 | 2023-11-13 | 1 | 2024-07-12 | View Edit Delete | ||||||||||||
| 764702 | 1231781001 | SPEXOTRAS 0,05 MG/ML POLVO PARA SOLUCION ORAL | SPEXOTRAS 0,05 MG/ML POLVO PARA SOLUCION ORAL, 1 frasco | 0,05 mg/ml | 6 | 180 | 26 | 1 frasco | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1231781001/1231781001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231781001/1231781001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 28642 | 1945 | 2024-04-10 | 1 | 1 | 1 | 2024-04-11 | 2024-04-10 | 1 | 2025-05-05 | View Edit Delete |